Stabilization and enhancement of interleukin-2 in vitro bioactivity by new carriers: supramolecular biovectors
- 31 December 1994
- Vol. 12 (15) , 1413-1418
- https://doi.org/10.1016/0264-410x(94)90150-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Evaluation of the new serum-free medium (MDSS2) for the production of different biologicals: Use of various cell linesCytotechnology, 1994
- Immobilized IL-2 preserves the viability of an IL-2 dependent cell lineMolecular Immunology, 1993
- Interleukin-2 in liposomes: Increased intravenous potency and less pulmonary toxicity in the ratDrug Development Research, 1992
- Appraisal of rabies vaccine potency by determination of in vitro, specific interleukin-2 productionBiologicals, 1991
- Enhancement of interleukin-2 activity by liposomesVaccine, 1990
- Interleukin-2: Inception, Impact, and ImplicationsScience, 1988
- Characterization of recombinant glycosylated human interleukin 2 produced by a recombinant plasmid transformed CHO cell lineFEBS Letters, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- The Interleukin-2 T-Cell System: A New Cell Growth ModelScience, 1984
- Heterogeneity of human T-cell growth factor(s) due to variable glycosylationMolecular Immunology, 1981